How to buy Hologic stock (HOLX)

Hologic is a medical instruments & supplies business based in the US. Hologic shares (HOLX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $70.76 – a decrease of 3.92% over the previous week. Hologic employs 6,990 staff and has a trailing 12-month revenue of around $4 billion.

Our top picks for where to buy Hologic stock

Buy Hologic stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Hologic stock price (NASDAQ: HOLX)

Use our graph to track the performance of HOLX stocks over time.

Hologic shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$70.76
52-week range	$70.53 - $84.67
50-day moving average more info button	$79.03
200-day moving average more info button	$77.80
Wall St. target price	$86.84
PE ratio more info button	21.5271
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$3.32

Is it a good time to buy Hologic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hologic price performance over time

Historical closes compared with the close of $71.47 from 2024-12-18

1 week (2024-12-13)	-2.96%
1 month (2024-11-20)	-8.42%
3 months (2024-09-20)	-12.19%
6 months (2024-06-20)	-1.02%

1 year (2023-12-20)	1.64%
2 years (2022-12-20)	-3.55%
3 years (2021-12-20)	77.18
5 years (2019-12-20)	37.39%

Is Hologic stock undervalued or overvalued?

Valuing Hologic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hologic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hologic's P/E ratio

Hologic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Hologic shares trade at around 22x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Hologic's PEG ratio

Hologic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.8894. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hologic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Hologic's EBITDA

Hologic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 billion.

The EBITDA is a measure of a Hologic's overall financial performance and is widely used to measure a its profitability.

Hologic financials

Revenue TTM	$4 billion
Operating margin TTM	24.36%
Gross profit TTM	$2.5 billion
Return on assets TTM	6.45%
Return on equity TTM	13.85%
Profit margin	17.59%
Book value	$21.94
Market Capitalization more info button	$16.2 billion

TTM: trailing 12 months

Hologic share dividends

We're not expecting Hologic to pay a dividend over the next 12 months.

Have Hologic's shares ever split?

Hologic's shares were split on a 2:1 basis on 2 April 2008 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hologic shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Hologic shares which in turn could have impacted Hologic's share price.

Hologic share price volatility

Over the last 12 months, Hologic's shares have ranged in value from as little as $70.53 up to $84.67. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hologic's is 0.986. This would suggest that Hologic's shares are less volatile than average (for this exchange).

Hologic overview

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures.

Frequently asked questions

null
What percentage of Hologic is owned by insiders or institutions?
Currently 0.802% of Hologic shares are held by insiders and 105.308% by institutions. How many people work for Hologic?
Latest data suggests 6,990 work at Hologic. When does the fiscal year end for Hologic?
Hologic's fiscal year ends in September. Where is Hologic based?
Hologic's address is: 250 Campus Drive, Marlborough, MA, United States, 01752 What is Hologic's ISIN number?
Hologic's international securities identification number is: US4364401012 What is Hologic's CUSIP number?
Hologic's Committee on Uniform Securities Identification Procedures number is: 436440101